494 related articles for article (PubMed ID: 32255127)
21. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
[TBL] [Abstract][Full Text] [Related]
22. Temporally Controlled Photothermal/Photodynamic and Combined Therapy for Overcoming Multidrug Resistance of Cancer by Polydopamine Nanoclustered Micelles.
Xing Y; Ding T; Wang Z; Wang L; Guan H; Tang J; Mo D; Zhang J
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13945-13953. PubMed ID: 30907570
[TBL] [Abstract][Full Text] [Related]
23. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
Sun W; Du Y; Liang X; Yu C; Fang J; Lu W; Guo X; Tian J; Jin Y; Zheng J
Biomaterials; 2019 Oct; 217():119264. PubMed ID: 31260883
[TBL] [Abstract][Full Text] [Related]
24. Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy.
Xie L; Li J; Wang G; Sang W; Xu M; Li W; Yan J; Li B; Zhang Z; Zhao Q; Yuan Z; Fan Q; Dai Y
J Am Chem Soc; 2022 Jan; 144(2):787-797. PubMed ID: 34985903
[TBL] [Abstract][Full Text] [Related]
25. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
[TBL] [Abstract][Full Text] [Related]
26. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
[TBL] [Abstract][Full Text] [Related]
27. Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy.
Liu F; He X; Lei Z; Liu L; Zhang J; You H; Zhang H; Wang Z
Adv Healthc Mater; 2015 Mar; 4(4):559-68. PubMed ID: 25471617
[TBL] [Abstract][Full Text] [Related]
28. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
Duan X; Chan C; Guo N; Han W; Weichselbaum RR; Lin W
J Am Chem Soc; 2016 Dec; 138(51):16686-16695. PubMed ID: 27976881
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
[TBL] [Abstract][Full Text] [Related]
31. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
[TBL] [Abstract][Full Text] [Related]
32. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer.
Wang P; Zhong W; Huang Q; Zhu Y; Chen L; Ye K
ACS Biomater Sci Eng; 2024 May; 10(5):3136-3147. PubMed ID: 38663028
[TBL] [Abstract][Full Text] [Related]
33. A Three-In-One Assembled Nanoparticle Containing Peptide-Radio-Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer-Immunity Cycle to Trigger Antitumor Immune Response.
Zhu X; Wang X; Li B; Zhang Y; Chen Y; Zhang W; Wang Y; Zhai W; Liu Z; Liu S; Sun J; Chen Z; Gao Y
Small; 2022 May; 18(20):e2107001. PubMed ID: 35434938
[TBL] [Abstract][Full Text] [Related]
34. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
Chen B; Huang R; Zeng W; Wang W; Min Y
Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
[TBL] [Abstract][Full Text] [Related]
35. Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy.
Zhou Z; Jiang N; Chen J; Zheng C; Guo Y; Ye R; Qi R; Shen J
J Nanobiotechnology; 2021 Nov; 19(1):375. PubMed ID: 34794446
[TBL] [Abstract][Full Text] [Related]
36. PEGylated reduced-graphene oxide hybridized with Fe
Wang L; Wang M; Zhou B; Zhou F; Murray C; Towner RA; Smith N; Saunders D; Xie G; Chen WR
J Mater Chem B; 2019 Dec; 7(46):7406-7414. PubMed ID: 31710067
[TBL] [Abstract][Full Text] [Related]
37. Polydopamine-Coated Manganese Carbonate Nanoparticles for Amplified Magnetic Resonance Imaging-Guided Photothermal Therapy.
Cheng Y; Zhang S; Kang N; Huang J; Lv X; Wen K; Ye S; Chen Z; Zhou X; Ren L
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19296-19306. PubMed ID: 28508635
[TBL] [Abstract][Full Text] [Related]
38. Gold Nanorods-Based Smart Nanoplatforms for Synergic Thermotherapy and Chemotherapy of Tumor Metastasis.
Li B; Wang Y; He J
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7800-7811. PubMed ID: 30720270
[TBL] [Abstract][Full Text] [Related]
39. Facile synthesis of hollow mesoporous nickel sulfide nanoparticles for highly efficient combinatorial photothermal-chemotherapy of cancer.
Yang R; Li R; Zhang L; Xu Z; Kang Y; Xue P
J Mater Chem B; 2020 Sep; 8(34):7766-7776. PubMed ID: 32744285
[TBL] [Abstract][Full Text] [Related]
40. A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
Sun Y; Han R; Wang J; Qin Y; Ren Z; Feng X; Liu Q; Wang X
J Control Release; 2022 Oct; 350():734-747. PubMed ID: 36063959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
